Skip to main content
. 2021 Mar 22;12:646940. doi: 10.3389/fimmu.2021.646940

Figure 1.

Figure 1

Longitudinal CSF findings and disease course of AIE patients. x axis: time between LP in days; mRS, modified ranking scale; AZA, azathioprine; Bortezomib: bortezomib; CYC, cyclophosphamide; Steroids methylprednisolone; IVIG, intravenous immunoglobulins; MTX, methotrexate; PLEX, plasma exchange; IA, immunoadsorption; RTX, rituximab.